Chemomab Therapeutics Ltd. (CMMB)
CMMB Stock Price Chart
Explore Chemomab Therapeutics Ltd. interactive price chart. Choose custom timeframes to analyze CMMB price movements and trends.
CMMB Company Profile
Discover essential business fundamentals and corporate details for Chemomab Therapeutics Ltd. (CMMB) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
12 Feb 2019
Employees
20.00
Website
https://www.chemomab.comCEO
Adi Mor George
Description
Chemomab Therapeutics Ltd. operates as a clinical-stage biotechnology firm, dedicated to identifying and advancing novel treatments for inflammatory and fibrotic conditions. Its leading experimental drug candidate, CM-101, is a humanized monoclonal antibody specifically engineered to impede the core function of soluble chemokine CCL24. This potential therapy is currently under investigation for its efficacy in managing primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc). Established in 2011, the company, formerly known as Anchiano Therapeutics Ltd., adopted its current name, Chemomab Therapeutics Ltd., in March 2021 and is headquartered in Tel Aviv, Israel.
CMMB Financial Timeline
Browse a chronological timeline of Chemomab Therapeutics Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 Aug 2026
EPS estimate is -$0.04.
Earnings released on 14 May 2026
EPS came in at -$0.22 falling short of the estimated -$0.04 by -450.00%.
Earnings released on 19 Mar 2026
EPS came in at -$0.24 falling short of the estimated -$0.20 by -20.00%.
Earnings released on 13 Nov 2025
EPS came in at -$0.80 falling short of the estimated -$0.20 by -300.00%.
Stock split effective on 26 Aug 2025
Shares were split 1 : 4 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Aug 2025
EPS came in at -$0.36 surpassing the estimated -$0.80 by +55.00%.
Earnings released on 15 May 2025
EPS came in at -$0.14 surpassing the estimated -$0.20 by +30.00%.
Earnings released on 3 Mar 2025
EPS came in at -$0.16 surpassing the estimated -$0.20 by +20.00%.
Earnings released on 14 Nov 2024
EPS came in at -$0.20 matching the estimated -$0.20.
Earnings released on 21 Aug 2024
EPS came in at -$0.26 falling short of the estimated -$0.20 by -30.00%.
Earnings released on 9 May 2024
EPS came in at -$0.28 falling short of the estimated -$0.20 by -40.00%.
Earnings released on 7 Mar 2024
EPS came in at -$0.26 surpassing the estimated -$0.40 by +35.00%.
Earnings released on 9 Nov 2023
EPS came in at -$0.34 surpassing the estimated -$0.60 by +43.33%.
Earnings released on 14 Aug 2023
EPS came in at -$0.72 surpassing the estimated -$0.80 by +10.00%.
Earnings released on 11 May 2023
EPS came in at -$0.80 matching the estimated -$0.80.
Earnings released on 20 Mar 2023
EPS came in at -$0.72 surpassing the estimated -$0.80 by +10.00%.
Earnings released on 11 Nov 2022
EPS came in at -$0.70 falling short of the estimated -$0.60 by -16.67%.
Earnings released on 12 Aug 2022
EPS came in at -$0.54 surpassing the estimated -$0.60 by +10.00%.
Earnings released on 12 May 2022
EPS came in at -$0.44 falling short of the estimated -$0.40 by -10.00%.
Earnings released on 9 Mar 2022
EPS came in at -$0.44 falling short of the estimated -$0.40 by -10.00%.
Earnings released on 12 Nov 2021
EPS came in at -$0.26 falling short of the estimated -$0.15 by -79.31%.
Earnings released on 13 Aug 2021
EPS came in at -$0.26 falling short of the estimated -$0.12 by -126.09%.
CMMB Stock Performance
Access detailed CMMB performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
